Senior Director Clinical Biomarkers, BioPharma Business Development

The Senior Director Clinical Biomarkers, BioPharma Business Development will provide strategic, scientific, and organizational leadership across a broad oncology diagnostics portfolio. This executive will be responsible for defining and advancing biomarker and translational medicine strategies across early- and late-stage BioPharma collaborations in support of Natera’s strategic goals eg TOMR and surrogacy in collaboration with Natera’s lifecycle and clinical development teams. The ideal candidate will bring deep expertise in oncology drug development, biomarker strategy, and translational research, with experience spanning Phase 1–3 studies and multiple therapeutic modalities, including immunotherapy, targeted therapy, and antibody-drug conjugates. Key Responsibilities  Lead translational medicine and clinical biomarker strategy across oncology programs within and beyond the BioPharma BD portfolio.  Define and oversee biomarker plans supporting late-stage development in solid tumors within the BioPharma space (Pharma Lab Services, BD partnerships) including assay strategy, translational endpoints, data generation, data interpretation, publication planning, and regulatory filing support.  Partner closely with clinical development, bioinformatics, medical affairs, regulatory, diagnostics, and commercial teams to ensure assay development portfolio and biomarker strategies are...